{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-051663","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2025-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.179775+00:00","generated_at":"2026-05-23T19:33:00.508271+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Eledon Pharmaceuticals dismisses Crowe LLP, appoints Deloitte as auditor","bullets":["Audit Committee dismissed Crowe LLP as independent auditor effective April 1, 2025.","No disagreements or reportable events in fiscal years 2023 and 2024 or interim period.","Crowe's audit reports for 2023 and 2024 were unqualified and not modified.","Deloitte & Touche LLP appointed as new auditor for fiscal year ending Dec 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-051663","json":"https://secwatch.observer/filing/0000950170-25-051663.json","markdown":"https://secwatch.observer/filing/0000950170-25-051663.md","text":"https://secwatch.observer/filing/0000950170-25-051663.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025051663/0000950170-25-051663-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025051663/eldn-20250401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T19:33:00.508271+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}